Evidence map›Paper›PMID 29581221›Full record

ArticleJournal of the American Heart Association2018

Impact of Type 2 Myocardial Infarction (MI) on Hospital-Level MI Outcomes: Implications for Quality and Public Reporting.

Sameer Arora, Paula D Strassle, Arman Qamar, Evan N Wheeler, Alexandra L Levine, Jacob A Misenheimer, Matthew A Cavender, George A Stouffer, Prashant Kaul

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Long-term clinical outcomes of type 1Cardiovascular diagnosis and therapy · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Acute Myocardial Infarction Cohorts Defined byCirculation. Cardiovascular quality and outcomes · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sameer AroraDivision of Cardiology and McAllister Heart Institute, University of North Carolina at Chapel Hill, NC saror@email.unc.edu.
Paula D StrassleDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, NC.
Arman QamarDivision of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Evan N WheelerCampbell University School of Osteopathic Medicine, Lillington, NC.
Alexandra L LevineCampbell University School of Osteopathic Medicine, Lillington, NC.
Jacob A MisenheimerDivision of Cardiology, Medical College of Georgia at Augusta University, Augusta, GA.
Matthew A CavenderDivision of Cardiology and McAllister Heart Institute, University of North Carolina at Chapel Hill, NC.
George A StoufferDivision of Cardiology and McAllister Heart Institute, University of North Carolina at Chapel Hill, NC.
Prashant KaulDivision of Cardiology and McAllister Heart Institute, University of North Carolina at Chapel Hill, NC.

Funding

TRAINING PROGRAM IN CARDIOVASCULAR RESEARCHT32HL007604 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MARK W FEINBERG · 1985 to 2026
$19.0M
NHLBI NIH HHS T32 HL007604
6 · The paper itself

Abstract

backgroundThe METHODS AND

resultsWe conducted a single-center retrospective analysis of 1318 patients discharged with a diagnosis of NSTEMI between July 2013 and October 2014. The Third Universal Definition was used to define type 1 and type 2 MI. Weighted Kaplan-Meier curves were used to analyze risk of mortality and readmission. Overall, 1039 patients met NSTEMI criteria per the Third Universal Definition; of those, 264 (25.4%) had type 2 MI. Patients with type 2 MI were older, were more likely to have chronic kidney disease, and had lower peak troponin levels. Compared with type 1 MI patients, those with type 2 MI had higher inpatient mortality (17.4% versus 4.7%,

conclusionsNSTEMI metrics are significantly affected by type 2 MI patients. Type 2 MI patients have distinct etiologies, are managed differently, and have higher mortality compared with patients with type 1 MI. Moving forward, it may be appropriate to exclude type 2 MI data from NSTEMI quality metrics.

Indexed as

HospitalizationOutcome and Process Assessment, Health CareQuality Indicators, Health CareAgedAged, 80 and overCause of DeathFemaleHospital MortalityHumansMaleMiddle AgedNon-ST Elevated Myocardial InfarctionPatient ReadmissionRetrospective StudiesRisk AssessmentRisk Factorscoronary artery diseasemortalitymyocardial infarctionreadmissiontroponin

Identifiers

PMID29581221
PMCPMC5907605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.